The European Lung Cancer Congress (ELCC 2022), from 30 March-2 April 2022, was held virtually this year and showcased recent developments in the prevention, screening, and early detection of thoracic malignancies, as well as the current and emerging contribution of precision medicine, big data and artificial intelligence, biomarkers and liquid biopsies in the optimal management of patients with lung cancer.